Price
Target price
€1.54
€1.54
11.680%
0.1608
11.680%
€10.20
18:31 / Tradegate
WKN: A1C3EQ / Symbol: PACB / Name: PacBio / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pacific Biosciences of California Inc. Stock
Pacific Biosciences of California Inc. dominated the market today, gaining €0.16 (11.680%).
Currently there is a rather positive sentiment for Pacific Biosciences of California Inc. with 11 Buy predictions and 5 Sell predictions.
With a target price of 10 € there is potential for a 550.53% increase which would mean more than doubling the current price of 1.54 € for Pacific Biosciences of California Inc..
Our community identified positive and negative aspects for Pacific Biosciences of California Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Pacific Biosciences of California Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Pacific Biosciences of California Inc. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Pacific Biosciences of California Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Pacific Biosciences of California Inc. | 11.680% | -56.249% | -59.302% | -86.345% | -85.303% | -94.769% | -79.177% |
| MicroVision Inc | -1.550% | -12.365% | -16.420% | -29.933% | -45.500% | -85.190% | 46.581% |
| Fonar Corp. New | -1.910% | -7.784% | -22.613% | 5.479% | -12.994% | 2.667% | -9.826% |
| Allscripts Healthcare | 2.780% | 0.000% | 17.460% | -33.333% | -20.000% | -42.636% | -10.412% |
Comments
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Sanford C. Bernstein from $9.00 to $2.50. They now have an "outperform" rating on the stock.
Show more
Ratings data for PACB provided by MarketBeat
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Show more
Ratings data for PACB provided by MarketBeat
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $9.00 to $7.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PACB provided by MarketBeat
